A baby formula display shelf is seen at a Walmart grocery store in Orlando. (Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images)
By Matt Ott
The maker of Enfamil announced a recall of about 145,000 cans of infant formula due to the possibility of cross-contamination with a bacteria that can cause serious illness or death.
Reckitt, a U.K.-based consumer health and nutrition company, said over the weekend that is voluntarily recalling two batches of Enfamil ProSobee Simply Plant-Based Infant Formula, but that no illnesses or “adverse events” have been reported. The company said it identified the cause of the potential cronobacter contamination and are no longer using the supplier.
According to the the U.S. Centers for Disease Control and prevention, cronobacter infections in infants can be deadly. The bacteria occurs naturally in soil, water and other parts of the environment and can live in dry foods, such as powdered milk, herbal teas, starches and baby formula.
Almost all previous outbreaks in the U.S. have been linked to powdered baby formulas, which don’t undergo the same high temperatures used to kill germs in many other foods. Cronobacter typically causes fever in infants and can sometimes lead to dangerous blood infections or swelling of the brain.
Last year, a nationwide baby formula shortage was triggered by an Abbott Nutrition plant that had to be closed for months because of contamination problems.
Abbott recalled various lots of three powdered infant formulas from the plant, after federal officials began investigating rare bacterial infections in four babies who were fed formula. Two of the infants died. But it’s not certain the bacteria came from the plant; strains found at the plant didn’t match the two available samples from the babies.
For the most recent recall, consumers should check the packaging of their formula to make sure they didn't purchase the recalled product. The product is Enfamil ProSobee Powder, 12.9 ounce can with a UPC number of 300871214415; global batch number of ZL2HZF or ZL2HZZ; lot number of 0670975 or 0670979 and an expiration date of March 1, 2024.
Consumers can return the product to wherever they bought it for a full refund. They can also call Reckit at 1-800-479-0551 or email the company at consumer.relations (at) rb.com.
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
U.S. sports betting is booming as NFL and college football fuel massive activity. BetMGM CEO Adam Greenblatt breaks down trends, growth, and what’s next.
President Donald Trump says a deal struck by Netflix last week to buy Warner Bros. Discovery “could be a problem” because of the size of the combined market share. The Republican president says he will be involved in the decision about whether federal regulators should approve the deal. Trump commented Sunday when he was asked about the deal as he walked the red carpet at the Kennedy Center Honors. The $72 billion deal would bring together two of the biggest players in television and film and potentially reshape the entertainment industry.
Disney's changes to a program for disabled visitors are facing challenges in federal court and through a shareholder proposal. The Disability Access Service program, which allows disabled visitors to skip long lines, was overhauled last year. Disney now mostly limits the program to those with developmental disabilities like autism who have difficulty waiting in lines. The changes have sparked criticism from some disability advocates. A shareholder proposal submitted by disability advocates calls for an independent review of Disney's disability policies. Disney plans to block this proposal, claiming it's misleading. It's the latest struggle by Disney to accommodate disabled visitors while stopping past abuses by some theme park guests.
With a merger this big, creators, studios, and theaters all face uncertain futures. Here’s what experts are worried about and what good could come from it.
With disengagement rising and hybrid work shifting, 'Everybody Matters' author Bob Chapman explains why treating people well could define the future of work.
